Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: Implications for passive and active immunization

Journal of Experimental Medicine

Volumn 187, Issue 4, 1998, Pages 649-654

  Seiler, Peter ^a   Bründler, Marie Anne ^a,c   Zimmermann, Christine ^a,d   Weibel, Doris ^a   Bruns, Michael ^b   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; THIOGLYCOLIC ACID; VIRUS GLYCOPROTEIN;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTECTION; SPLEEN CELL; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS MENINGITIS; VIRUS NEUTRALIZATION; VIRUS PLAQUE; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; FEMALE; IMMUNIZATION, PASSIVE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RHABDOVIRIDAE INFECTIONS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL VACCINES;

EID: 2642662484     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.4.649     Document Type: Article

References (31)

1. Haynes, B.F., G. Pantaleo, and A.S. Fauci. 1996. Toward an understanding of the correlates of protective immunity to HIV infection. Science. 271:324-328.
2. Steiner, I. 1996. Human herpes viruses latent infection in the nervous system. Immunol. Rev. 152:157-173.
3. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA. 94:6874-6879.
4. Battegay, M., D. Kyburz, H. Hengartner, and R.M. Zinkernagel. 1993. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells. Eur. J. Immunol. 23:3236-3241.
5. Halstead, S.B., and E.J. O'Rourke. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146:201-217.
6. Hany, M., S. Oehen, M. Schulz, H. Hengartner, M. Mackett, D.H.L. Bishop, and R.M. Zinkernagel. 1989. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur. J. Immunol. 19:417-424.
7. Mackett, M., T. Yilma, J.K. Rose, and B. Moss. 1985. Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science. 227:433-435.
8. Fung-Leung, W.P., M.W. Schilham, A. Rahemtulla, T.M. Kündig, M. Vollenweider, J. Potter, W. van Ewijk, and T.W. Mak. 1991. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell. 65:443-449.
9. Bruns, M., J. Cihak, G. Müller, and F. Lehmann-Grube. 1983. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization. Virology. 130:247-251.
10. Zeller, W., M. Bruns, and G.F. Lehmann. 1986. Viral nucleoprotein can be demonstrated on the surface of lymphocytic choriomeningitis virus-infected cells. Med. Microbiol. Immunol. 175:89-92.
11. Cobbold, S.P., A. Jayasuriya, A. Nash, T.D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature. 312:548-551.
12. Roost, H.P., M.F. Bachmann, A. Haag, U. Kalinke, V. Pliska, H. Hengartner, and R.M. Zinkernagel. 1995. Early high affinity neutralizing anti-viral IgG without affinity maturation during a virus infection. Proc. Natl. Acad. Sci. USA. 92:1257-1261.
13. Battegay, M., S. Cooper, A. Althage, J. Baenziger, H. Hengartner, and R.M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 or 96 well plates. J. Virol. Methods. 33:191-198.
14. + T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent interleukins. J. Immunol. 146:4301-4307.
15. Charan, S., A.W. Hügin, A. Cerny, H. Hengartner, and R.M. Zinkernagel. 1986. Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice. J. Virol. 57:1139-1144.
16. b molecule. Nature. 348:213-216.
17. Pircher, H.P., D. Moskophidis, U. Rohrer, K. Bürki, H. Hengartner, and R.M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature. 346:629-633.
18. Schulz, M., F. Aichele, M. Vollenweider, F.W. Bobe, F. Cardinaux, H. Hengartner, and R.M. Zinkernagel. 1989. MHC-dependent T cell epitopes of LCMV nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19:1657-1667.
19. Zinkernagel, R.M., T.P. Leist, H. Hengartner, and A. Althage. 1985. Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. J. Exp. Med. 162:2125-2141.
20. Baldridge, J.R., and M.J. Buchmeier. 1992. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J. Virol. 66:4252-4257.
21. Bachmann, M.F., U. Kalinke, A. Althage, G. Freer, C. Burkhart, H.-P. Roost, M. Aguet, H. Hengartner, and R.M. Zinkernagel. 1997. The role of antibody concentration and avidity in antiviral protection. Science. 276:2024-2027.
22. Zinkernagel, R.M., S. Cooper, J. Chambers, R.A. Lazzarini, H. Hengartner, and H. Arnheiter. 1990. Virus-induced autoantibody response to a transgenic viral antigen. Nature. 344: 68-71.
23. Bachmann, M.F., R.U. Hoffmann, T.M. Kündig, K. Bürki, H. Hengartner, and R.M. Zinkernagel. 1993. The influence of antigen organization on B cell responsiveness. Science. 262: 1448-1451.
24. Cole, G.A., N. Nathanson, and R.A. Prendergast. 1972. Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature. 238:335-337.
25. Doherty, P.C., and R.M. Zinkernagel. 1975. Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex. J. Immunol. 114:30-33.
26. Bangham, C.R.M. 1986. Passively acquired antibodies to respiratory syncytial virus impair the secondary cytotoxic T-cell response in the neonatal mouse. Immunology. 59:37-41.
27. Xiang, Z.Q., and H.C. Ertl. 1992. Transfer of maternal antibodies results in inhibition of specific immune responses in the offspring. Virus Res. 24:297-314.
28. Yap, K.L., and G.L. Ada. 1979. The effect of specific antibody on the generation of cytotoxic T lymphocytes and the recovery of mice from influenza virus infection. Scand. J. Immunol. 10:325-332.
29. Leung, K., R.B. Ashman, C. Hildegrund, J. Ertl, and G.L. Ada. 1980. Selective suppression of the cytotoxic T cell response to influenza virus in mice. Eur. J. Immunol. 10:803-810.
30. Planz, O., P. Seiler, H. Hengartner, and R.M. Zinkernagel. 1996. Specific cytotoxic T cells eliminate cells producing neutralizing antibodies. Nature. 382:726-728.
31. Koup, R.A., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.